SUNNYVALE, Calif., March 29 /PRNewswire/ -- B-Bridge International, Inc., a worldwide provider of tools and technology to life-science research laboratories, announced today the closure of $4.2 million in private investment. The major sources for this investment came from Bio-sight Capital Co, Ltd., headquartered in Osaka, Hokkaido Venture Capital, Inc., headquartered in Sapporo, and the Marubeni Corporation, headquartered in Tokyo, as well as from current shareholders.
In addition to ramping up its efforts to develop and commercialize new technology by expanding it research and development capability, the investment will enable B-Bridge to develop an infrastructure that connects investigators with the latest technology and services more effectively and rapidly than current sales and distribution systems.
According to Hiro Masumoto, President and CEO of B-Bridge International, "Advances in life-science research benefit us all by improving health, medical treatment, agriculture, and our understanding of the environment. B-Bridge's vision is to accelerate this type of research by providing easy access to the latest tools and services for researchers all over the world. This funding will enable us to begin development of a network infrastructure that provides researchers with more information and faster access to tools and services that enhance their research efforts."
After starting as a small trading company in 2000, B-Bridge has steadily built up a several million dollar business. Hiromi Abe, B-Bridge CFO, stated that, "After five years of continuous growth, B-Bridge is ready to take the next step. It is rewarding that our investors had the confidence in our experience, achievement, and vision to provide us with this opportunity."
B-Bridge International -- founded in 2000 and based in Sunnyvale, California -- provides quality tools and technology to advance global discovery in biotechnology. With access to worldwide markets in the academic, government, pharmaceutical and biotechnology sectors, B-Bridge fosters the development and availability of new technology through manufacturing, distribution, and incubation.
To learn more about B-Bridge International, please visit http://www.b-bridge.com/.
Contact: Paul Diehl of B-Bridge, +1-408-735-7727, or email@example.com.
B-Bridge International, Inc.